C. Scalici Gesolfo

Clinical implications of a rare renal entity: Pleomorphic Hyalinizing Angiectatic Tumor (PHAT).

R. Montironi, E. Barresi, V. Franco, 2017, Pathology, research and practice.

Characterization of human infiltrating and circulating gamma-delta T cells in prostate cancer

D. Coniglio, S. Meraviglia, V. Serretta, 2019, Investigative and clinical urology.

Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study

M. Valerio, V. Serretta, C. Pavone, 2020, Urologia Internationalis.

Sexual dysfunctions after transurethral resection of the prostate (TURP): evidence from a retrospective study on 264 patients.

D. Fontana, C. Pavone, C. Scalici Gesolfo, 2015, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?

G. Cicero, M. Moschini, R. Colombo, 2015, Urologia Internationalis.

Mitomycin C from Birth to Adulthood

V. Serretta, F. di Maida, C. Scalici Gesolfo, 2016, Urologia.

Fibronectin urothelial gene expression as a new reliable biomarker for early detection of local toxicity secondary to adjuvant intravesical therapy for non-muscle invasive bladder cancer

L. Lambertini, M. Carini, A. Minervini, 2021, Therapeutic advances in urology.

EGFR CELL EXPRESSION IN BLADDER WASHINGS AS A RISK MARKER TOOL IN NON MUSCLE‐INVASIVE BLADDER CANCER. PRELIMINARY EXPERIENCE: MP44‐20

A. Russo, V. Serretta, F. di Maida, 2017 .

Cancer of the Penis

A. Simonato, A. Abrate, C. Scalici Gesolfo, 2021, Practical Medical Oncology Textbook.

An uncommon case of sarcomatoid urothelial carcinoma in covered bladder exstrophy

D. Fontana, C. Pavone, A. Cordova, 2016, Case reports in plastic surgery & hand surgery.

Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?

M. Valerio, V. Gebbia, F. Verderame, 2019, Urologic oncology.

Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression.

M. Carini, A. Minervini, A. Russo, 2019, Clinical genitourinary cancer.

Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?

G. Cicero, M. Moschini, R. Colombo, 2015, Urologia Internationalis.